Insider Transactions in Q2 2021 at Humanigen, Inc (HGEN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
219,256
-1.86%
|
$3,727,352
$17.28 P/Share
|
|
Jun 25
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
1,000,000
-7.82%
|
$17,000,000
$17.8 P/Share
|
|
Jun 24
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
139,529
-1.08%
|
$2,511,522
$18.37 P/Share
|
|
Jun 23
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
133,126
-1.02%
|
$2,396,268
$18.28 P/Share
|
|
Jun 18
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
402,480
-2.99%
|
$7,244,640
$18.5 P/Share
|
|
Jun 17
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
181,423
-1.33%
|
$3,447,037
$19.17 P/Share
|
|
Jun 16
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
158,486
-1.19%
|
$3,011,234
$19.43 P/Share
|
|
Jun 14
2021
|
Cameron Durrant Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
81,441
-30.73%
|
$1,628,820
$20.78 P/Share
|
|
Jun 08
2021
|
Edward P. Jordan Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
14,700
-100.0%
|
$294,000
$20.08 P/Share
|
|
Jun 08
2021
|
Edward P. Jordan Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,700
+50.0%
|
$132,300
$9.65 P/Share
|
|
Jun 07
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
80,636
-0.84%
|
$1,532,084
$19.08 P/Share
|
|
Jun 04
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
127,084
-1.3%
|
$2,287,512
$18.46 P/Share
|
|
Jun 03
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
191,154
-1.91%
|
$3,440,772
$18.37 P/Share
|
|
Jun 02
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
76,126
-0.76%
|
$1,446,394
$19.01 P/Share
|